Although these findings require further consolidation on larger patient cohorts, they confirm a homogeneous higher expression level of the ATP1A1/BCL2L1 ratio in mature AML subtypes, more vulnerable to CGs. Here, BCL2L1 is linked to acute myeloid leukemia.